Dr
Jade
Cheng

Patent Attorney

London Office

Life sciences

Telephone. +44 (0)207 776 5100
Email. [email protected]

Experience

Jade joined the Life Sciences group of HGF in February 2022 as a qualified UK and European Patent Attorney.

Prior to being a Patent Attorney, Jade was a postdoctoral fellow at the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge. During her time as an academic, she investigated diverse subjects including the blood brain barrier, mechanisms of cell death and embryonic development.

Jade’s experience in academia means she understands the patenting process from academics' point of view and is ideally placed to work alongside universities’ technology transfer departments and their academics.

Jade’s main areas of focus in patent practice are on antibodies, vaccines and medical treatments. She has experience with drafting and filing applications, prosecution, freedom-to-operate analyses, third party observations, EPO oppositions and appeals, and providing filing strategies. She also advises clients on prosecution in many foreign jurisdictions.

Jade enjoys being a member of the HGF Venture team with Kerry Rees to provide IP due diligence services to life science investors. As a consequence, Jade also works with early stage companies to help them align their IP strategies with their business plan to maximum the return on investment.

Jade is fluent in English and Cantonese.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Biochemistry

PHD

Biochemistry

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Dot Inc, the accessible future and more: health tech highlights coming to CES 2023

The countdown is on for CES 2023. Taking place in Las Vegas in the first week of January each year, CES sets the global stage for innovation in the tech …

Read article

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.